New intranasal cross-linked mosapride xyloglucan pluronics micelles (MOS-XPMs) for reflux esophagitis disease: In-vitro optimization and improved therapeutic efficacy

por Hammad, Reham Waheed, Sanad, Rania Abdel-Basset, Abdelmalak, Nevine Shawky, Torad, Faisal A., Latif, Randa
Publicado 2020